CLINICAL_TRIALS
trial_result
· 2023-08-01
Clinical Trial Update: COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications [Phase 2]
Summary
Phase 2 pilot trial of fisetin for COVID-19-related dysfunction and complications has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James L. Kirkland, MD, PhD | Conditions: Covid19, Coronavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01